What is Theravance Biopharma's net debt?

Theravance Biopharma (TBPH) reported net debt of -$247.6M in Q1 2026.

How has Theravance Biopharma's net debt changed year-over-year?

Theravance Biopharma's net debt decreased by 296.4% year-over-year, from -$62.46M to -$247.6M.

What is the long-term trend for Theravance Biopharma's net debt?

Over 5 years (2020 to 2025), Theravance Biopharma's net debt has grown at a 38.7% compound annual growth rate (CAGR), from -$24.38M to -$125.1M.

What does net debt mean?

Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.

Theravance Biopharma TBPH Net debt

Discontinued — last reported Q1 '26

Net debt at other companies

Cabot CorporationCBT

1.1×-0.3×

Travel + LeisureTNL

6×+1.6×

UnifirstUNF

-0.2×-0.1×

HES

Hess MidstreamHESM

3.1×-0.1×

TDA

USA TODAY Co., Inc.TDAY

8.8×+4.2×

Resolute Holdings Management RHLD

11.8×+10.5×

Other financials

Income statement

See full

Revenue$17.7M+15.0%

Operating income-$9.5M+34.3%

Net income-$4.9M+63.7%

EPS (diluted)-$0.10+63.0%

Balance sheet

See full

Cash & equivalents$288.1M+160%

Total debt$40.5M-15.9%

Total equity$290.6M+75.1%

Total assets$472.3M+37.5%

Cash flow

See full

Operating cash flow$73.3M+70.3%

CapEx$8.0K-95.8%

Free cash flow$59.6M+5,560%

Valuation

See full

Market cap$890.32M+67.5%

Enterprise value$642.72M+37.0%

P/E7.8×—

P/S8.1×0.0×

Profitability

See full

Gross margin60.8%—

Operating margin1.2%+0.6pp

Net margin104.3%+71.4pp

FCF margin221.9%+206pp

Returns & leverage

See full

Return on equity50.2%+36.2pp

Debt / equity0.1×-0.2×

Current ratio13.1×+8.4×

Where this comes from

Calculated from Theravance Biopharma’s reported figures.

$40.5Mtotal debt−$288.1Mcash and equivalents=-$247.6M

The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Theravance Biopharma's net debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Theravance Biopharma's net debt?: Theravance Biopharma (TBPH) reported net debt of -$247.6M in Q1 2026.
How has Theravance Biopharma's net debt changed year-over-year?: Theravance Biopharma's net debt decreased by 296.4% year-over-year, from -$62.46M to -$247.6M.
What is the long-term trend for Theravance Biopharma's net debt?: Over 5 years (2020 to 2025), Theravance Biopharma's net debt has grown at a 38.7% compound annual growth rate (CAGR), from -$24.38M to -$125.1M.
What does net debt mean?: Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.